Do we need new drugs against human African trypanosomiasis?

The Lancet Infectious Diseases

Volumn 13, Issue 9, 2013, Pages 733-734

  Stich, August ^a   Ponte Sucre, Alicia ^b   Holzgrabe, Ulrike ^c  

^a Medical Mission Hospital   (Germany)

^b UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPANOSOMAL AGENT; EFLORNITHINE; EFLORNITHINE PLUS NIFURTIMOX; FEXINIDAZOLE; MELARSOPROL; NIFURTIMOX; PENTAMIDINE; SURAMIN; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; ALLERGIC REACTION; BLOOD BRAIN BARRIER; DIARRHEA; DRUG DEVELOPMENT; DRUG EFFICACY; EPIDEMIC; GASTROINTESTINAL SYMPTOM; GLUCOSE IMBALANCE; HAIR LOSS; HEADACHE; HEALTH CARE SYSTEM; HEMATOLOGIC DISEASE; HUMAN; HYPOTENSION; LETTER; MUSCULOSKELETAL DISEASE; NEPHROTOXICITY; NEUROPATHY; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; REACTIVE ENCEPHALOPATHY; TREATMENT DURATION; VERTIGO; WORLD HEALTH ORGANIZATION;

ANIMALS; CLINICAL TRIALS AS TOPIC; DISEASE OUTBREAKS; DRUG EVALUATION, PRECLINICAL; EFLORNITHINE; HUMANS; NEGLECTED DISEASES; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN;

EID: 84882607924     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70191-9     Document Type: Letter

References (8)

1. Research priorities for Chagas disease, human African trypanosomiasis and leishmaniasis. World Health Organ Tech Rep Ser 2012, 975:1-100. WHO.
2. Bisser S, Courtioux B Sleeping sickness: end of the epidemic outbreak?. Rev Neurol (Paris) 2012, 168:230.
3. Simarro PP, Cecchi G, Franco JR, et al. Risk for human African trypanosomiasis, Central Africa, 2000-2009. Emerg Infect Dis 2011, 17:2322.
4. Steverding D The history of African trypanosomiasis. Parasites & Vectors 2008, 1:3.
5. Simarro PP, Franco J, Diarra A, et al. Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis. Parasitology 2012, 139:842.
6. Mäser P, Wittlin S, Rottmann M, et al. Antiparasitic agents: new drugs on the horizon. Curr Opin Pharmacol 2012, 14:1.
7. Kennedy PG An alternative form of melarsoprol in sleeping sickness. Trends Parasitol 2012, 28:307.
8. Baker N, de Koning HP, Mäser P, Horn D Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story. Trends Parasitol 2013, 29:110.